Neoadjuvant therapy reduces node positivity but does not confer survival benefit versus up-front resection for resectable intrahepatic cholangiocarcinoma: A propensity-matched analysis.

Chase J WehrleJenny ChangKimberly P WooAbby GrossRobert NaplesFadi DahdalehKathryn StackhouseJaekeun KimToms AugustinRobert SimonDaniel JoyceDavid C H KwonCharles MillerR Matthew WalshFederico AucejoSamer Naffouje

Published in: Journal of surgical oncology (2024)

NAST for iCCA was associated with improved quality of oncologic resection but did not confer an OS benefit versus up-front resection.

Keyphrases

rectal cancer
lymph node
locally advanced
radiation therapy
bone marrow
minimally invasive
liver metastases
cell therapy